Clinical trials
Phase 1 trials in Uganda
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 10 |
| University of Oxford | 3 |
| EuroVacc Foundation | 2 |
| Fred Hutchinson Cancer Center | 2 |
| International AIDS Vaccine Initiative | 2 |
| Center for Innovative Public Health Research | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Columbia University | 1 |
| Crucell Holland BV | 1 |
| Gates Medical Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 10 |
| Malaria | 5 |
| Acquired Immunodeficiency Syndrome | 4 |
| Hemorrhagic Fever, Ebola | 2 |
| Adenoviridae Infections | 1 |
| Anemia, Sickle Cell | 1 |
| Asphyxia Neonatorum | 1 |
| Burkitt Lymphoma | 1 |
| COVID-19 | 1 |
| Coinfection | 1 |
Trials
Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.